Scientists propose a new model for Alzheimer’s disease that may explain the high failure rate of recent clinical trials.
Neurologist Scott A. Small participated in a Kavli Foundation roundtable on the link between the brain's ability to make new cells and age-related memory loss.
CUMC researchers have clarified three fundamental issues about Alzheimer's: where it starts, why it starts there, and how it spreads.
Columbia's 2013 Horwitz winners: Edvard Moser, May-Britt Moser & John O’Keefe for findings that could lead to new Alzheimer's treatments.
A Columbia-led research team has clinically validated a new method for predicting time to nursing home residence or death for patients with Alzheimer’s.
A study has uncovered 11 new genes that increase the chance of developing Alzheimer’s disease and provide new clues to ways to fighting it.